Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

While antitrust lawsuits and Capitol Hill hearings get headlines, Big Tech's biggest threat in Washington may come from the Federal Trade Commission.

Why it matters: The FTC is gearing up to flex its muscle, by both enforcing current rules and trying to draft new ones. And it may be able do so relatively quickly.

Driving the news: Acting FTC chair Rebecca Kelly Slaughter has created a new "rulemaking group" within the agency's general counsel's office, positioning the FTC to draft new rules cracking down on anti-competitive corporate behavior.

  • The move signals that Slaughter aims to be more aggressive than her recent predecessors, who focused on consumer protection issues like fraud.
  • It's also a signal to the Biden administration — which hasn't nominated a permanent FTC chair yet — that if Slaughter gets the gig, she's open to testing all the agency's legal authority to keep Big Tech in check.
  • FTC rulemakings could apply to multiple companies at once. For the platform companies, potential regulations could focus on app stores, data security and transparency in algorithms.

Big Tech can also expect the FTC, which has the power to police companies' "unfair and deceptive" practices, to take more aggressive enforcement actions under the Biden administration, including lawsuits.

  • Slaughter has suggested the FTC's recent settlements didn't go far enough, and she argues that executives should be held personally liable for violations.
  • She criticized the agency's $5 billion fine against Facebook in 2019, stemming from the Cambridge Analytica data leak, saying it was too small and that Facebook and CEO Mark Zuckerberg should have been referred to the Justice Department for litigation.

Yes, but: The FTC is a relatively small agency with limited resources.

  • New rulemaking is a cumbersome process, and there are chances for stakeholders to slow it down even further. Congress added some speed bumps to the FTC’s processes in the 1970s, as lawmakers believed it was overstepping its bounds with moves like trying to ban some children's TV advertising.
  • Rulemakings are used sparingly on relatively narrow issues or when directed by Congress.
  • Expanding the use of its rulemaking authority would be new ground for the FTC, and there's no guarantee it will work.
  • Antitrust suits don't always work out, either. The agency last week abandoned its 4-year-long case accusing Qualcomm of using its dominance to squash competition. Slaughter said she still believes Qualcomm broke antitrust laws, but that the FTC faced "significant headwinds."
  • Still, even failure to enact new rules could help the FTC argue that it doesn't have the tools it needs and persuade Congress to give it more authority.

What to watch: President Biden recently nominated Lina Khan for FTC commissioner. Khan's legal analysis on Amazon helped propel the narrative that the Big Tech companies have too much power.

  • Biden hasn't yet named a replacement for the panel's third Democrat, Rohit Chopra, who's been nominated to lead the Consumer Financial Protection Bureau.
  • Khan was previously a legal adviser to Chopra, who has argued that the FTC has the authority to make new rules targeting anti-competitive practices.

What's next: The FTC's actions have been relatively bipartisan and noncontroversial in the past. But antitrust attorneys and former staffers say the FTC will likely become more partisan as it tries to take full advantage of its legal authorities.

Go deeper

Biden says "right verdict" in Chauvin trial is "overwhelming"

President Biden told reporters Tuesday that he's "come to know" George Floyd's family and that he's "praying the verdict is the right verdict" in Derek Chauvin's trial, as the nation awaits the jury's decision.

Why it matters: Officials fear a not-guilty decision in the high-profile case could inflame racial tensions and set off a new wave of riots. The jury was sequestered and entered deliberation after closing arguments on Monday.

3 hours ago - World

After nuclear talks, Iran's president says deal could be reached soon

Hassan Rouhani. Photo: Iranian Presidency Handout via Getty

Iranian President Hassan Rouhani said Tuesday, after another round of nuclear talks in Vienna, that an agreement can be reached in a short time if the U.S. acts with "honesty."

Why it matters: Rouhani’s optimism comes as representatives of Iran and other world powers, including the U.S., are about to start drafting a plan to restore the 2015 nuclear deal.

4 hours ago - Health

EU regulator: Benefits of J&J vaccine outweigh risk of rare blood clots

Photo: Allen J. Schaben / Los Angeles Times via Getty Images

The European Medicines Agency (EMA) said Tuesday that unusual blood clots should be listed as a "very rare" side effects of Johnson & Johnson's coronavirus vaccine, but that the benefits of the shot still outweigh the risks.

Why it matters: The agency's determination of a "possible link" to a rare kind of blood clot comes ahead of an expected ruling by the U.S. FDA this week on whether to lift its pause on the J&J vaccine rollout.